Impact of TH and DCX mRNAs detection in high-risk neuroblastoma patients' outcome

被引：0
|
作者：
Canete, A. [1 ]
Yanez, Y. [1 ]
Grau, E. [1 ]
Palanca, S. [2 ]
Perez, G. [2 ]
Antuna, M. J. [3 ]
Marquez, C. [4 ]
Gallego, S. [5 ]
Urberuaga, A. [6 ]
Castel, V. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Mol Biol Lab, Valencia, Spain
[3] Hosp Univ Cent Asturias, Asturias, Spain
[4] Hosp Univ Virgen del Rocio, Seville, Spain
[5] Hosp Univ Vall dHebron, Barcelona, Spain
[6] Hosp Univ Cruces, Vizcaya, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1624
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [31] Results of single and double autografts for high-risk neuroblastoma patients
    KawaHa, K
    YumuraYagi, K
    Inoue, M
    Park, DY
    Okamura, T
    Yasui, M
    Oota, H
    Sakata, N
    Yoneda, M
    Imura, K
    BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 957 - 962
  • [32] Profile of Neuroblastoma Patients Using the "Ultra High-Risk" Classification
    Peralta-Velazquez, V.
    Purizaca, J.
    Vazquez-Mena, O.
    Paredes-Serrano, M.
    Rivera-Sanchez, N.
    Vega-Vega, L.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S205 - S205
  • [33] Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
    Spasov, Neofit
    Spasova, Mariya
    CASE REPORTS IN PEDIATRICS, 2021, 2021
  • [34] The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
    Greenwood, Katie L.
    Foster, Jennifer H.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1257 - 1262
  • [35] Allogeneic Stem Cell Transplantation for High-Risk Neuroblastoma Patients
    Choeyprasert, W.
    Hongeng, S.
    Pakakasama, S.
    Anurathapan, U.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S244 - S245
  • [36] Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
    Lee, Ji Won
    Son, Meong Hi
    Cho, Hee Won
    Ma, Young Eun
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    PEDIATRIC BLOOD & CANCER, 2018, 65 (10)
  • [37] Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma
    Gillis, Amy M.
    Sutton, Elizabeth
    DeWitt, Kelly D.
    Matthay, Katherine K.
    Weinberg, Vivian
    Fisch, Benjamin M.
    Chan, Albert
    Gooding, Charles
    Daldrup-Link, Heike
    Wara, William M.
    Farmer, Diana L.
    Harrison, Michael R.
    Haas-Kogan, Daphne
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 858 - 864
  • [38] RNAseq identified immune signatures associated with adverse outcome in high-risk neuroblastoma
    Wei, Jun S.
    Zhang, Shile
    Kuznetsov, Igor
    Song, Young K.
    Asgharzadeh, Shahab
    Sindiri, Sivasish
    Wen, Xinyu
    Patidar, Rajesh
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    Seeger, Robert
    Maris, John M.
    Khan, Javed
    CANCER RESEARCH, 2017, 77
  • [39] The Impact of Gross Total Resection on Survival in Children with High-Risk Neuroblastoma
    Komatsu, Shugo
    Saito, Takeshi
    Terui, Keita
    Nakata, Mitsuyuki
    Harada, Kazuaki
    Shinno, Yoshitaka
    Katsumi, Daisuke
    Furugane, Ryoya
    Yoshida, Hideo
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S39 - S39
  • [40] PRE-OPERATIVE THROMBOCYTOPENIA IN PATIENTS AFFECTED BY HIGH RISK NEUROBLASTOMA: IMPACT ON SURGICAL OUTCOME
    Persano, Giorgio
    Beati, Federico
    Martucci, Cristina
    Frediani, Simone
    Madafferi, Silvia
    Voglino, Valerio
    De Iorsi, Maria Antonietta
    Serra, Annalisa
    Di Paolo, Pier Luigi
    Natali, Gian Luigi
    Stracuzzi, Alessandra
    Alaggio, Rita
    Crocoli, Alessandro
    Inserra, Alessandro
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S177 - S177
12345